Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it will raise CNY 20 million in a equity round of funding on September 23, 2021. The transaction include participation from Guangzhou Anbiping No. 1 Investment Partnership Enterprise (Limited Partnership), Guangzhou Anbiping No. 2 Investment Partnership Enterprise (Limited Partnership) and returning investor Guangzhou LBP Medicine Science & Technology Co., Ltd. The transaction was approved by the board of directors in its 9th session of the companys 3rd directorate. The company's registered capital will increase from CNY10 million to CNY 30 million. The investors will hold 5%, 15% and 80% stake respectively after the transaction with investment of CNY 4,500,000, CNY 1,500,000 and CNY 24,000,000 respectively.